Polyamine analogues inhibit the ubiquitination of spermidine/spermine N-1-acetyltransferase and prevent its targeting to the proteasome for degradation

Citation
Cs. Coleman et Ae. Pegg, Polyamine analogues inhibit the ubiquitination of spermidine/spermine N-1-acetyltransferase and prevent its targeting to the proteasome for degradation, BIOCHEM J, 358, 2001, pp. 137-145
Citations number
46
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL JOURNAL
ISSN journal
02646021 → ACNP
Volume
358
Year of publication
2001
Part
1
Pages
137 - 145
Database
ISI
SICI code
0264-6021(20010815)358:<137:PAITUO>2.0.ZU;2-M
Abstract
Spermidine/spermine N-1-acetyltransferase (SSAT), a key enzyme in mammalian polyamine catabolism, undergoes rapid turnover (half-life approx. 30 min) and is highly inducible in response to polyamine analogues such as bis(ethy l)spermine (BE-3-4-3), which greatly stabilize the enzyme. Rapid degradatio n of SSAT in reticulocyte lysates was preceded by formation of a ladder of ubiquitinated forms, and required the production of high-molecular-mass com plexes with ubiquitin (HMM-SSAT-Ubs). Mutation of all 11 lysines in SSAT se parately to arginine demonstrated that no single lysine residue is critical for its degradation in vitro, but mutant K87R had a significantly longer h alf-life, suggesting that lysine-87 may be the preferred site for ubiquitin ation. Mutations at the C-terininus of SSAT, such as E171Q, resulted in mar ked stabilization of the protein, due to the lack of formation of the HMM-S SAT-Ubs. Addition of BE-3-4-3 prevented the accumulation of ubiquitin conju gates and the proteasomal degradation of wild-type SSAT. These results indi cate that conformational changes brought about by the binding of polyamine analogues prevent the efficient polyubiquitination of SSAT, leading to a ma jor increase in the amount of SSAT protein, and that alteration of the C-te rminal end of the protein has a similar effect in preventing the productive interaction with an E2 or E3 component of the ubiquitin pathway.